Detalles de la búsqueda
1.
MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 25(5): 603-613, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38588682
2.
The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 203(2): 339-349, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37878148
3.
Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
Breast Cancer Res Treat
; 205(2): 287-302, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381274
4.
Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.
Breast Cancer Res Treat
; 198(2): 239-251, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36635428
5.
The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry.
Breast Cancer Res Treat
; 192(2): 331-342, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35025003
6.
Disease-free and overall survival after neoadjuvant chemotherapy in breast cancer: breast-conserving surgery compared to mastectomy in a large single-centre cohort study.
Breast Cancer Res Treat
; 185(2): 441-451, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33073303
7.
Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry.
Breast Cancer Res Treat
; 188(2): 571-581, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743103
8.
Quality of life and illness perceptions in patients with breast cancer using a fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 DIRECT (BOOG 2013-14) trial.
Breast Cancer Res Treat
; 185(3): 741-758, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179154
9.
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res
; 21(1): 97, 2019 08 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-31455425
10.
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I-IIIB breast cancer receiving chemotherapy.
Breast Cancer Res Treat
; 173(2): 475-481, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30353244
11.
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(12): 1688-1700, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146401
12.
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res
; 18(1): 3, 2016 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26738606
13.
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Cancer
; 122(19): 2961-70, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27315546
14.
Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer: Results From the SONABRE Registry.
Clin Breast Cancer
; 24(2): 103-111, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38007349
15.
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.
NPJ Breast Cancer
; 9(1): 61, 2023 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452019
16.
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer: an observational study of the SONABRE Registry.
Lancet Reg Health Eur
; 26: 100573, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36895447
17.
Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced Cancer.
JAMA Netw Open
; 5(11): e2244350, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36449290
18.
Quantification of ribociclib in dried blood spots by LC-MS/MS: Method development and clinical validation.
J Pharm Biomed Anal
; 201: 114118, 2021 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000578
19.
Impact on Quality of Documentation and Workload of the Introduction of a National Information Standard for Tumor Board Reporting.
JCO Clin Cancer Inform
; 4: 346-356, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32324446
20.
Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial.
Nat Commun
; 11(1): 3083, 2020 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32576828